Actavis Inc.

Watson Pharmaceuticals, Inc. is Now Actavis, Inc. (PICTURE)

Watson to Acquire Actavis Group for EUR 4.25 Billion

Parsippany, NJ (ots) - - Creates 3rd largest global generics company - - ~$8.0 billion anticipated pro forma combined revenue in 2012 - - Significantly increases scale of Watson's ex-U.S. generic business- - Accelerates revenue and earnings growth - - Immediately accretive to non-GAAP earnings, before synergies - - Greater than $300 million annual synergies anticipated within 3 years - - Strong combined cash flow allows ...

New Actavis/Bioton alliance to shake up diabetes market / Global managed-care offering to help bring down treatment costs for 366 million diabetics

Warsaw, Poland (ots) - Actavis and Bioton (WSE:BIO) announced today that they have formed a joint venture company for the development and registration of insulins, including analogue insulins. Within the framework of the joint-venture, Bioton will be responsible for the development and manufacture of insulin ...

Actavis donates EUR 2M worth of medicines to Libya

Zejtun, Malta (ots) - "We know Libya is faced with shortages of essential supplies. That's why Actavis donates EUR 2M worth of medicines to Libya now. The goods will leave Malta on Sunday and arrive in Tripoli during next week", said Actavis CEO Claudio Albrecht. "Actavis is one of the world's largest generic pharmaceutical players and takes its social responsibility very seriously." Mr. Albrecht emphasized the role of ...

'Youth in Europe' drug prevention programme sees youth drinking drop from 42% to 9% / Iceland and Actavis continue to support the fight against substance abuse